Back
Intra-Cellular Therapies Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
ITCI
Intra-Cellular Therapies
Last Price:
$131.47
Seasonality Move:
6.95%
7 Day Trial
ALL ACCESS PASS
$
7
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.28 | Buy |
| 20-day SMA: | 129.79 | Buy |
| 50-day SMA: | 121.36 | Buy |
| 200-day SMA: | 88.14 | Buy |
| 8-day EMA: | 131.06 | Buy |
| 20-day EMA: | 129.42 | Buy |
| 50-day EMA: | 120.67 | Buy |
| 200-day EMA: | 94.44 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.68 | Buy |
| Relative Strength Index (14 RSI): | 84.35 | Buy |
| Chaikin Money Flow: | 891836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.64 - 130.96) | Buy |
| Bollinger Bands (100): | (80.74 - 124.78) | Buy |
Intra-Cellular Therapies Technical Analysis
| Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 131.45 while ITCI 8-day simple moving average is 131.28, which is a Buy signal.
-
The stock price of ITCI is 131.45 while Intra-Cellular Therapies 20-day SMA is 129.79, which makes it a Buy.
-
Intra-Cellular Therapies 50-day simple moving average is 121.36 while ITCI share price is 131.45, making it a Buy technically.
-
ITCI stock price is 131.45 and Intra-Cellular Therapies 200-day simple moving average is 88.14, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Buy
59
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a BuyThe current Intra-Cellular Therapies [ITCI] share price is $131.45. The Score for ITCI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
14B
Price in USD:
131.45
Share Volume:
996.8K
Intra-Cellular Therapies 52-Week Range
52-Week High:
131.46
52-Week Low:
63.87
Buy
59
Intra-Cellular Therapies (ITCI)
is a Buy
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?The Intra-Cellular Therapies stock price is 131.45 USD today.
-
Will ITCI stock go up or go down?Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators
-
Is Intra-Cellular Therapies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is not overvalued.
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 131.45 while ITCI 8-day exponential moving average is 131.06, which is a Buy signal.
-
The stock price of ITCI is 131.45 while Intra-Cellular Therapies 20-day EMA is 129.42, which makes it a Buy.
-
Intra-Cellular Therapies 50-day exponential moving average is 120.67 while ITCI share price is 131.45, making it a Buy technically.
-
ITCI stock price is 131.45 and Intra-Cellular Therapies 200-day simple moving average is 94.44, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $3.58 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
-
ITCI Moving Average Covergence Divergence (MACD) indicator is 2.68, suggesting Intra-Cellular Therapies is a Buy
-
Intra-Cellular Therapies Relative Strength Index (RSI) is 84.35, which suggest Intra-Cellular Therapies is overbought
-
The Bollinger Bands (25) for Intra-Cellular Therapies is (127.64 - 130.96), which suggest Intra-Cellular Therapies is a Buy
-
The Bollinger Bands (100) for Intra-Cellular Therapies is (80.74 - 124.78), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.